[(2R,3R,4S,5R,6R)-4,5-diacetyloxy-6-[[(4-sulfamoylbenzoyl)amino]carbamothioylamino]-3-[(2S,3R,4S,5S,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl acetate

InChIKey	`WDFBMSONXFYEHT-FJYVYTOGSA-N`
Compound Name	[(2R,3R,4S,5R,6R)-4,5-diacetyloxy-6-[[(4-sulfamoylbenzoyl)amino]carbamothioylamino]-3-[(2S,3R,4S,5S,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl acetate
Canonical SMILES	`CC(=O)OC[C@H]1O[C@@H](O[C@H]2[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](NC(=S)NNC(=O)c3ccc(S(N)(=O)=O)cc3)O[C@@H]2COC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H]1OC(C)=O`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	5
Pfam Stratification	Cross-Family
Avg pChEMBL	8.1
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P00918	CA2	Homo sapiens	Human	PF00194	8.2	Ki	ChEMBL;BindingDB
P18505	GABRB1	Homo sapiens	Human	PF02931 PF02932	8.2	pIC50	TTD_MultiTarget
O43570	CA12	Homo sapiens	Human	PF00194	8.1	Ki	ChEMBL;BindingDB
Q16790	CA9	Homo sapiens	Human	PF00194	8.1	Ki	ChEMBL;BindingDB
Q9ULX7	CA14	Homo sapiens	Human	PF00194	8.0	Ki	ChEMBL;BindingDB